filmov
tv
Oxford University’s COVID-19 Vaccine Shows Promising Results In Phase 1 and 2 Trials
Показать описание
Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot.
COVID Conversations: Sarah Gilbert on Vaccines
AstraZeneca’s Oxford Vaccine Shows Promise, Produces Immunity In Young & Old Adults
COVID-19: AstraZeneca-Oxford vaccine shows promising results among elderly
Oxford's COVID-19 vaccine shows promising immune response in human trials
Oxford vaccine prompts protective immune response in human trials
New Oxford COVID-19 study shows getting the virus has higher risks than getting vaccine
Oxford's COVID-19 vaccine shows promising immune response in human trials
A look at the biotech facility producing Oxford's COVID-19 vaccine
Oxford Covid Vaccine Shows Good Immune Response With Two-Dose Regime
Oxford's scientists explain the Phase I/II results for the COVID-19 vaccine
Oxford University Researchers Testing Coronavirus Vaccine That Could Be Ready Soon
COVID 19 UPDATE 4 - Oxford Vaccine Against Coronavirus | ChAdOx1 nCoV-19 Vaccine or COVID 19 Vaccine
Oxford-AstraZeneca coronavirus vaccine shows 70% efficacy | World News | WION News
Annual Lecture with Person of the Year: Prof Sarah Gilbert, Oxford Project Leader COVID-19 Vaccine
Oxford-AstraZeneca trial shows its vaccine is 79% effective
U.K. Expands Fight Against Covid-19 With New Oxford-AstraZeneca Vaccine | NBC News NOW
Insights into the technologies behind the COVID-19 vaccines in development
Oxford AstraZeneca Vaccine Effective But Questions Remain for Elderly
WION Fineprint: Oxford COVID-19 vaccine early trail shows positive results
Latest vaccine news out of Oxford are 'very encouraging,' says health strategist
Coronavirus Vaccine Update: Oxford COVID-19 Vaccine Early Trial Shows Positive Result
Oxford study shows COVID vaccine effective leaving Macron & EU red-faced
Oxford Study: Better Get That COVID Vaccine
COVID-19 vaccine developed by Oxford University develops promising immune response in human trial
Комментарии